Lallemand Pharma AG
🇨🇭Switzerland
Clinical Trials
9
Active:0
Completed:9
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (50.0%)Phase 2
1 (16.7%)Phase 3
1 (16.7%)Phase 4
1 (16.7%)Survey of Incidence of Respiratory Tract Infections
Completed
- Conditions
- Healthy AdultsNot Healthy Adults
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Lallemand Pharma AG
- Target Recruit Count
- 1736
- Registration Number
- NCT06649032
- Locations
- 🇮🇹
Dr F Pugliese, Bari, Italy
🇮🇹Università degli Studi di Cagliari, Cagliari, Italy
🇮🇹Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
Prevention With Healsea in Adults Against Respiratory Infection Study
Not Applicable
Completed
- Conditions
- Healthy Subjects (HS)
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Lallemand Pharma AG
- Target Recruit Count
- 198
- Registration Number
- NCT06613906
- Locations
- 🇧🇬
Diagnostics and Consultation Center Convex EOOD,, Sofia, Bulgaria
HEALSea Nasal Spray for Prevention of Infections in Children
Phase 2
Completed
- Conditions
- Healthy Subjects
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Lallemand Pharma AG
- Target Recruit Count
- 139
- Registration Number
- NCT06582589
- Locations
- 🇧🇬
Multiprofile Hospital for Active Treatment Sveti Ivan Rilski -2003 OOD, Dupnitsa, Bulgaria
🇧🇬Medical Center Plovdimed Ltd, Plovdiv, Bulgaria
🇧🇬Medical Center Iskar EOOD, Sofia, Bulgaria
BАbykids Spray In Common Cold
Not Applicable
Completed
- Conditions
- Common ColdRhinitis Viral
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Lallemand Pharma AG
- Target Recruit Count
- 200
- Registration Number
- NCT05819203
- Locations
- 🇧🇬
Medical center, Vratsa, Bulgaria
Testing the Efficacy in Adults With Cold of HEalsea Rescue*
Not Applicable
Completed
- Conditions
- Common Cold
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Lallemand Pharma AG
- Target Recruit Count
- 200
- Registration Number
- NCT05819190
- Locations
- 🇧🇬
DCC Convex Ltd., Sofia, Bulgaria
- Prev
- 1
- 2
- Next
News
No news found